Meropenem Venus Pharma

Meropenem, the active ingredient in Meropenem Venus Pharma, is a carbapenem presented as an injectable powder for intravenous use. It treats a range of severe bacterial infections in hospitalized patients. GNH USA supplies Meropenem Venus Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections. - Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitic pathogens. - Severe sepsis: offers rapid bactericidal activity in systemic infection. - Hospital‑acquired pneumonia: targets multidrug‑resistant organisms in ventilated patients.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Diarrhea: mild to moderate loose stools. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in transaminases. - Phlebitis at infusion site: irritation of peripheral veins.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile colitis: pseudomembranous colitis risk. - Hemolytic anemia: rare immune‑mediated red cell destruction. - Thrombocytopenia: low platelet counts. - Renal dysfunction: acute kidney injury in susceptible individuals.

Meropenem should be used with caution in specific clinical situations. - Renal impairment: adjust dose based on creatinine clearance. - CNS disorders: monitor for neurotoxicity, especially seizures. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Hypersensitivity: avoid in patients with known β‑lactam allergy. - Concomitant valproic acid: may reduce serum levels, monitor seizure control. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several medications.

Major Interactions (Avoid): - Valproic acid: reduces valproate levels, risking loss of seizure control. - Probenecid: decreases renal clearance, increasing meropenem exposure.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: potential for electrolyte disturbances; observe serum electrolytes. - Anticoagulants (e.g., warfarin): may alter INR; check coagulation parameters.